Edge Advisors’s Globus Medical GMED Stock Holding History

Edge Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-405	Closed	-$20K	–	857
2018 Q1	$20K	Hold	405	–	–	﹤0.01%	645
2017 Q4	$16K	Hold	405	–	–	﹤0.01%	697
2017 Q3	$12K	Hold	405	–	–	﹤0.01%	709
2017 Q2	$13K	Hold	405	–	–	﹤0.01%	713
2017 Q1	$11K	Sell	405 -26	-6%	-$710	﹤0.01%	743
2016 Q4	$10K	Buy	+431	New	+$9.79K	﹤0.01%	689

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Edge Advisors's GMED Position: Q2 2018 in Review

Edge Advisors sold out of Globus Medical (GMED) in Q2 2018, closing a stake of 405 shares — an estimated $20K sold.

Edge Advisors first reported a position in GMED in Q4 2016 and held it in 6 quarters. The position peaked at $20K in Q1 2018. 290 funds tracked by Wall St. Rank hold GMED as of Q2 2018.

Edge Advisors reported no remaining Globus Medical position as of Q2 2018 after selling out during the quarter.
Edge Advisors sold 405 Globus Medical shares in Q2 2018, an estimated $20K.
Edge Advisors first reported a position in Globus Medical in Q4 2016 and held it in 6 quarters.
Edge Advisors's Globus Medical position peaked at $20K in Q1 2018.
290 funds tracked by Wall St. Rank held Globus Medical as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.